Genalyte has announced that its rapid Covid-19 serology panel is available on its Maverick platform. The SARS-CoV-2 Multi-Antigen Serology Panel detects the presence of IgG and IgM antibodies, which are produced in bodies when infected by the SARS-CoV-2 virus that causes Covid-19. The company said that the panel uses a machine learning approach that enables it to remove false positives and achieve 100% specificity on a group of 300 negative patients.